| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 08/26/1999 | WO1999042444A1 Substituted isoindolones and their use as cyclic gmp modulators in medicaments |
| 08/26/1999 | WO1999042436A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 08/26/1999 | WO1999042089A2 Use of thiadiazolo[4,3-a]pyridine derivatives |
| 08/26/1999 | WO1999024462A3 Novel conjugates of rgd-containing peptides and endogenous carriers |
| 08/26/1999 | WO1998030696A8 Secreted proteins and polynucleotides encoding them |
| 08/26/1999 | WO1998004693A3 Secreted proteins and polynucleotides encoding them |
| 08/26/1999 | DE19807423A1 New isoindolone derivatives useful as soluble guanylate cyclase activators for treating cardiovascular disorders, asthma, renal insufficiency, diabetes, cirrhosis or cognitive dysfunction |
| 08/26/1999 | DE19807265A1 New adenoviral vector useful for gene therapy |
| 08/26/1999 | CA2321104A1 Azole peptidomimetics as thrombin receptor antagonists |
| 08/26/1999 | CA2320990A1 Method for the production of polymers from n-vinyl compounds |
| 08/26/1999 | CA2320469A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 08/26/1999 | CA2318237A1 Use of thiadiazolo[4,3-a]pyridine derivatives |
| 08/25/1999 | EP0937146A2 Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin |
| 08/25/1999 | EP0937141A1 Polynucleotides encoding secreted proteins from human dendritic cells |
| 08/25/1999 | EP0937073A2 Selective factor xa inhibitors |
| 08/25/1999 | EP0937048A1 HETEROCYCLE DERIVATIVES WHICH INHIBIT FACTOR Xa |
| 08/25/1999 | EP0937036A1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors |
| 08/25/1999 | EP0781436A4 System and method of automatically generating chemical compounds with desired properties |
| 08/25/1999 | EP0237545B2 Production of pluripotent granulocyte colony-stimulating factor |
| 08/25/1999 | CN1226895A Amino acid derivatives and their use as thrombin inhibitors |
| 08/25/1999 | CN1226832A Atrial natriuretic peptide (ANP) as additive to peritoneal dialysis solutions |
| 08/24/1999 | US5942620 Methods for producing novel conjugates of thrombin inhibitors |
| 08/24/1999 | US5942535 a!-Annelated pyrrole derivatives and pharmaceutical use thereof |
| 08/24/1999 | US5942488 Mutant human beta-globin modified to contain at leaset two non-wild type amino acid residues; enhanced bicarbonate effect |
| 08/24/1999 | CA2176974C Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 08/20/1999 | CA2261183A1 Adenoviral transfer vector for the gene transport of a dna sequence |
| 08/19/1999 | WO1999041283A1 Pf4 fragments and pharmaceutical compositions containing same |
| 08/19/1999 | WO1999041282A1 Therapeutic uses of keratinocyte growth factor-2 |
| 08/19/1999 | WO1999041254A1 NOVEL TRIAZOLO(4,5-d)PYRIMIDINE COMPOUNDS |
| 08/19/1999 | WO1999041246A1 Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors |
| 08/19/1999 | WO1999040867A1 Treatment of brain edema using carbonic anhydrase enzyme inhibitor |
| 08/19/1999 | WO1999040788A1 Inotropic and diuretic effects of exendin and glp-1 |
| 08/19/1999 | WO1999030670A3 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof |
| 08/19/1999 | WO1999024076A3 Salicylate derivatized therapeutic and diagnostic agents |
| 08/19/1999 | WO1999024074A3 Novel conjugates of opioids and endogenous carriers |
| 08/19/1999 | WO1999023996A3 Compositions containing red rice fermentation products, frementation processes and monascus strains therefor |
| 08/19/1999 | CA2320934A1 Treatment of brain edema using carbonic anhydrase inhibitor |
| 08/19/1999 | CA2320515A1 Therapeutic uses of keratinocyte growth factor-2 |
| 08/19/1999 | CA2319173A1 Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors |
| 08/19/1999 | CA2316264A1 Novel triazolo(4,5-d)pyrimidine compounds |
| 08/18/1999 | EP0935663A2 Multi-functional chimeric hematopoietic receptor agonists |
| 08/18/1999 | EP0935465A1 Novel substituted imidazole compounds |
| 08/18/1999 | EP0935415A1 Methods for delivering compounds into a cell |
| 08/18/1999 | CN1044679C Benzothiophene compounds new use |
| 08/17/1999 | US5939583 Antiarthritic agents; bone, cardiovascular, brain, nervous system disorders; antitumor and antimetastasis agents |
| 08/17/1999 | US5939540 Platelet secretory transport protein |
| 08/17/1999 | US5939415 A!-annellated pyrrole derivatives and their use in pharmacology |
| 08/17/1999 | US5939411 Piperidine derivatives substituted at position 4 with new functions other than those described previously have a high affinity for neurokinin receptors and are useful for treatment of substance p and neurokinin dependent pathologies |
| 08/17/1999 | US5939392 Thrombin inhibitors, anticoagulants and antiinflammatory agents |
| 08/17/1999 | US5939304 Reacting active serine of thrombin with enzyme inhibitor; alkali treatment at ph not less than 11; recovering product in presence of polyhydric alcohols, saccharides, and salt or amphoteric electrolyte preventing coagulation |
| 08/17/1999 | US5939063 Modified forms of granulocyte macrophage-colony stimulating factor as antagonists |
| 08/12/1999 | WO1999040220A2 Method of screening therapeutic agents |
| 08/12/1999 | WO1999040201A1 Protein |
| 08/12/1999 | WO1999040198A2 Identification, production and use of staphylokinase derivatives with reduced immunogenicity and/or reduced clearance |
| 08/12/1999 | WO1999040184A1 Dendritic enriched secreted lymphocyte activation molecule |
| 08/12/1999 | WO1999040183A1 Human serine protease and serpin polypeptides |
| 08/12/1999 | WO1999040106A2 Use of angiotensin analogues for promoting erythropoiesis |
| 08/12/1999 | WO1999040100A1 45 human secreted proteins |
| 08/12/1999 | WO1999040080A1 Hydroxamic and carboxylic acid derivatives |
| 08/12/1999 | WO1999040072A1 Five-membered, benzo-condensed heterocycles used as antithrombotic agents |
| 08/12/1999 | WO1999039747A1 Bipapcitide-based pharmaceutical compositions for imaging and treating thrombi |
| 08/12/1999 | WO1999000116A3 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| 08/12/1999 | CA2321175A1 Method of screening therapeutic agents |
| 08/12/1999 | CA2320625A1 45 human secreted proteins |
| 08/12/1999 | CA2319693A1 Identification, production and use of staphylokinase derivatives with reduced immunogenicity and/or reduced clearance |
| 08/12/1999 | CA2319644A1 Human serine protease and serpin polypeptides |
| 08/12/1999 | CA2319494A1 5-membered heterocyclic condensed benzoderivatives, the preparation thereof and their use as pharmaceuticals |
| 08/12/1999 | CA2319097A1 Dendritic enriched secreted lymphocyte activation molecule |
| 08/12/1999 | CA2317476A1 Hydroxamic and carboxylic acid derivatives |
| 08/11/1999 | EP0934928A1 Cyclic amine derivatives |
| 08/11/1999 | EP0934424A1 A process for producing a recombinant polypeptide involving the addition of an inhibitor of metal-dependent proteases or chymotrypsins to the cell culture medium |
| 08/11/1999 | EP0934411A1 Compositions for treating anemia |
| 08/11/1999 | EP0934310A1 THIO ACID DERIVED MONOCYCLIC $i(N)-HETEROCYCLICS AS ANTICOAGULANTS |
| 08/11/1999 | EP0934304A1 2-pyrimidineamine derivatives and processes for their preparation |
| 08/11/1999 | EP0934265A1 Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof |
| 08/11/1999 | EP0934064A1 Thrombin inhibitors |
| 08/11/1999 | EP0725651B1 Hemoregulatory peptides |
| 08/11/1999 | CN1225622A Substituted oxobutyric acids as matrix metalloprotease inhibitor |
| 08/11/1999 | CN1225621A Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids |
| 08/11/1999 | CN1225620A Substituted 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors |
| 08/11/1999 | CN1225367A Bond partner, and use for sieving inhibitor and diagnosis and treatment of disease |
| 08/10/1999 | US5935985 Phenoxyacetic acid derivatives |
| 08/10/1999 | US5935972 Benzofuran derivatives as tachykinin antagonists |
| 08/10/1999 | US5935935 Adenoviral vectors for treatment of hemophilia |
| 08/10/1999 | US5935930 Antithrombotic materials and methods |
| 08/10/1999 | US5935565 Method for increasing the level of stem cells in peripheral blood |
| 08/10/1999 | US5935437 Preparation of autologous plasma and fibrin gel |
| 08/10/1999 | CA1340704C Human interferon-gamma, process to prepare said human interferon-gamma, and its use |
| 08/05/1999 | WO1999038983A1 Novel sphingosine-1 phosphate lyase |
| 08/05/1999 | WO1999038843A1 Hydroxamic and carboxylic acid derivatives |
| 08/05/1999 | WO1999038827A1 PLATELET AGGREGATION INHIBITION USING LOW MOLECULAR WEIGHT HEPARIN IN COMBINATION WITH A GP IIb/IIIa ANTAGONIST |
| 08/05/1999 | WO1999025367A3 Treatment of hematologic disorders |
| 08/05/1999 | WO1999022721A3 Unsubstituted polydiallylamine for treating hypercholesterolemia |
| 08/05/1999 | WO1999011256A8 L-threonate ferrous, as well as pharmaceutical composition and use for improving and treating human anemia thereof |
| 08/05/1999 | WO1999000128A9 Antithrombotic agents |
| 08/05/1999 | CA2318215A1 Platelet aggregation inhibition using low molecular weight heparin in combination with a gp iib/iiia antagonist |
| 08/04/1999 | EP0933083A1 Process for the purification of serum albumin |
| 08/04/1999 | EP0932608A1 SELECTIVE FACTOR Xa INHIBITORS |
| 08/04/1999 | EP0932600A2 SULFONAMIDE SUBSTITUTED ASPARTIC ACID INTERLEUKIN-1$g(b) CONVERTING ENZYME INHIBITORS |
| 08/04/1999 | EP0932410A1 Mistletoe (viscum) extracts |